Following the dissemination of a corporate update and financial appraisal, the stock of iTeos Therapeutics, Inc. (NASDAQ: ITOS) has experienced a surge in value during
On December 31, news emerged that iTeos Therapeutics Inc. (ITOS) is set to join S&P SmallCap 600. Consequently, the stock rallied and became bullish in
The shares of iTeos Therapeutics Inc. (ITOS) were up 51.37% in premarket trading at $30.32. iTeos stock closed at $20.03 last session, up 0.86% or
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.